| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $46K | -39.4% |
| Cost of Revenue | $85K | +11.8% |
| Gross Profit | -$39K | — |
| R&D Expense | $889K | +1.8% |
| SG&A Expense | $3.6M | +11.2% |
| Operating Income | -$5.5M | -13.1% |
| Interest Expense | $64K | -89.5% |
| Pre-tax Income | -$7.0M | -42.4% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $454K | -55.6% |
| Accounts Receivable | $18K | +38.1% |
| Current Assets | $824K | -36.1% |
| Total Assets | $2.1M | -13.7% |
| Current Liabilities | $1.2M | -63.8% |
| Stockholders' Equity | $970K | +233.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | -44.5% |
| Capital Expenditures | $5K | — |
| Investing Cash Flow | -$322K | -169.4% |
| Financing Cash Flow | $5.0M | +51.6% |
| Free Cash Flow | -$5.3M | -44.7% |
| — |
| Net Income | -$7.0M | -42.4% |
| EPS (Basic) | -$7480.00 | — |
| EPS (Diluted) | -$7480.00 | — |